James D. Chambers

Economics, Econometrics and FinanceHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab”.

How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab

UNC Libraries(2020)10.17615/vvyw-sf39

N/A

0DataRank · unranked

0 citations

James D. Chambers, Stacie B. Dusetzina, G. Caleb Alexander, Nancy L. Keating, Haiden A. Huskamp +4 more

Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.29006

N/A

0DataRank · unranked

9 citations

Katherine A. Clifford, Daniel E. Enright, Peter J. Neumann, James D. Chambers